Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human micro-somal protein and …

…, J Brian Houston, BG Lake, JC Lipscomb… - Current drug …, 2007 - ingentaconnect.com
Reported predictions of human in vivo hepatic clearance from in vitro data have used a variety
of values for the scaling factors human microsomal protein (MPPGL) and hepatocellularity …

Metabolism of trichloroethylene.

…, JW Fisher, JC Lipscomb, JC Parker - Environmental health …, 2000 - ehp.niehs.nih.gov
A major focus in the study of metabolism and disposition of trichloroethylene (TCE) is to identify
metabolites that can be used reliably to assess flux through the various pathways of TCE …

Human health effects of trichloroethylene: key findings and scientific issues

…, KZ Guyton, N Keshava, JC Lipscomb… - Environmental …, 2013 - ehp.niehs.nih.gov
… Evans MV, Chiu WA, Okino MS, Caldwell JC. 2009. Development of an updated PBPK
model for trichloroethylene and metabolites in mice, and its application to discern the role of …

Evaluation of physiologically based pharmacokinetic models for use in risk assessment

…, B Sonawane, JC Lipscomb… - Journal of Applied …, 2007 - Wiley Online Library
Physiologically based pharmacokinetic (PBPK) models are sophisticated dosimetry models
that offer great flexibility in modeling exposure scenarios for which there are limited data. …

Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling

…, JR Harlow, JE Snawder, JC Lipscomb… - Drug Metabolism and …, 2008 - ASPET
Scaling of metabolic clearance values from liver microsomal data or recombinantly expressed
cytochrome P450 enzymes to predict human hepatic clearance requires knowledge of the …

In vitro measurements of metabolism for application in pharmacokinetic modeling

JC Lipscomb, TS Poet - Pharmacology & therapeutics, 2008 - Elsevier
Human risk and exposure assessments require dosimetry information. Species-specific
tissue dose response will be driven by physiological and biochemical processes. While …

Identification of developmentally toxic drinking water disinfection byproducts and evaluation of data relevant to mode of action

…, ES Hunter III, LK Teuschler, JC Lipscomb… - Toxicology and applied …, 2011 - Elsevier
Reactions between chemicals used to disinfect drinking water and compounds present in
source waters produce chemical mixtures containing hundreds of disinfection byproducts (…

Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment

JC Lipscomb, S Haddad, T Poet, K Krishnan - New Technologies for …, 2012 - Springer
Physiologically-based pharmacokinetic (PBPK) modeling offers a scientifically-sound framework
for integrating mechanistic data on absorption, distribution, metabolism and elimination …

Putative mechanisms of environmental chemical–induced steatosis

JP Kaiser, JC Lipscomb… - International journal of …, 2012 - journals.sagepub.com
Liver disease is a major health issue characterized by several pathological changes, with
steatosis (fatty liver) representing a common initial step in its pathogenesis. Steatosis is of …

Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk …

JE Snawder, JC Lipscomb - Regulatory Toxicology and Pharmacology, 2000 - Elsevier
Differences in biotransformation activities may alter the bioavailability or efficacy of drugs,
provide protection from certain xenobiotic and environmental agents, or increase toxicity of …